115 related articles for article (PubMed ID: 8547875)
1. Recombinant tissue plasminogen activator (rTPA) for hepatic veno-occlusive disease after allogeneic BMT in a pediatric patient.
Feldman L; Gabai E; Milovic V; Jaimovich G
Bone Marrow Transplant; 1995 Nov; 16(5):727. PubMed ID: 8547875
[No Abstract] [Full Text] [Related]
2. Recombinant human tissue plasminogen activator for the treatment of severe hepatic veno-occlusive disease in pediatric bone marrow transplant patients.
Leahey AM; Bunin NJ
Bone Marrow Transplant; 1996 Jun; 17(6):1101-4. PubMed ID: 8807121
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of veno-occlusive disease with recombinant tissue plasminogen activator in a patient requiring peritoneal dialysis.
Simpson DR; Browett PJ; Doak PB; Palmer SJ
Bone Marrow Transplant; 1994 Oct; 14(4):635-6. PubMed ID: 7858540
[TBL] [Abstract][Full Text] [Related]
4. No beneficial effects, but severe side effects caused by recombinant human tissue plasminogen activator for treatment of hepatic veno-occlusive disease after allogeneic bone marrow transplantation.
Hägglund H; Ringdén O; Ljungman P; Winiarski J; Ericzon B; Tydén G
Transplant Proc; 1995 Dec; 27(6):3535. PubMed ID: 8540088
[No Abstract] [Full Text] [Related]
5. [Treatment of hepatic veno-occlusive disease after bone marrow transplantation with recombinant human tissue plasminogen activator (rh-tPA)].
Yoshimi A; Kato K; Maeda N; Matsuyama T; Kojima S
Rinsho Ketsueki; 2000 Feb; 41(2):103-8. PubMed ID: 10723238
[TBL] [Abstract][Full Text] [Related]
6. A review of tissue plasminogen activator in the treatment of veno-occlusive liver disease after bone marrow transplantation.
Terra SG; Spitzer TR; Tsunoda SM
Pharmacotherapy; 1997; 17(5):929-37. PubMed ID: 9324182
[TBL] [Abstract][Full Text] [Related]
7. Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD).
Kulkarni S; Rodriguez M; Lafuente A; Mateos P; Mehta J; Singhal S; Saso R; Tait D; Treleaven JG; Powles RL
Bone Marrow Transplant; 1999 Apr; 23(8):803-7. PubMed ID: 10231143
[TBL] [Abstract][Full Text] [Related]
8. Recombinant tissue plasminogen activator for treatment of hepatic veno-occlusive disease following bone marrow transplantation in children: effectiveness and a scoring system for initiating treatment.
Bajwa RP; Cant AJ; Abinun M; Flood TJ; Hodges S; Hale JP; Skinner R
Bone Marrow Transplant; 2003 Apr; 31(7):591-7. PubMed ID: 12692627
[TBL] [Abstract][Full Text] [Related]
9. Double treatment of severe hepatic veno-occlusive disease after allogeneic peripheral blood progenitor cell transplantation with recombinant tissue plasminogen activator.
Söhngen D; Bauser U; Boogen C; Aul C; Frieling T; Germing U; Schneider P; Kobbe G; Heyll A
Thromb Haemost; 1997 Oct; 78(4):1299-300. PubMed ID: 9365005
[No Abstract] [Full Text] [Related]
10. Treatment of hepatic veno-occlusive disease with low-dose tissue plasminogen activator: impact on coagulation profile.
Goldberg SL; Shubert J; Rao AK; Redei I; Klumpp TR; Mangan KF
Bone Marrow Transplant; 1996 Sep; 18(3):633-6. PubMed ID: 8879629
[TBL] [Abstract][Full Text] [Related]
11. Fatal hemorrhage after recombinant tissue plasminogen activator therapy for hepatic veno-occlusive disease complicating autologous BMT.
Otheo de Tejada E; Maldonado MS; Camarero C; Muñoz A
Bone Marrow Transplant; 1994 Jul; 14(1):176-7. PubMed ID: 7951113
[No Abstract] [Full Text] [Related]
12. Veno-occlusive disease of the liver complicating ABMT successfully treated with recombinant tissue plasminogen activator (rt-PA).
Baglin TP; Harper P; Marcus RE
Bone Marrow Transplant; 1990 Jun; 5(6):439-41. PubMed ID: 2369685
[TBL] [Abstract][Full Text] [Related]
13. Hepatic veno-occlusive disease after tranexamic acid administration in patients undergoing allogeneic hematopoietic stem cell transplantation.
Mori T; Aisa Y; Shimizu T; Yamazaki R; Mihara A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Am J Hematol; 2007 Sep; 82(9):838-9. PubMed ID: 17506069
[TBL] [Abstract][Full Text] [Related]
14. Defibrotide as salvage therapy for refractory veno-occlusive disease of the liver complicating allogeneic bone marrow transplantation.
Abecasis MM; Conceição Silva JP; Ferreira I; Guimarães A; Machado A
Bone Marrow Transplant; 1999 Apr; 23(8):843-6. PubMed ID: 10231151
[TBL] [Abstract][Full Text] [Related]
15. Reversal of severe hepatic veno-occlusive disease by combined plasma exchange and rt-PA treatment.
Espigado I; Rodríguez JM; Parody R; Carmona M; Digón J; Olloqui E
Bone Marrow Transplant; 1995 Aug; 16(2):313-6. PubMed ID: 7581155
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of severe hepatic veno-occlusive disease after allogeneic bone marrow transplantation by transjugular intrahepatic portosystemic stent-shunt (TIPS).
Lévy V; Azoulay D; Rio B; Vincent F; Rabbat A; Hunault M; Bazarbachi A; Delmer A; Zittoun R
Bone Marrow Transplant; 1996 Aug; 18(2):443-45. PubMed ID: 8864460
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human tissue plasminogen activator without heparin is effective in the treatment of hepatic veno-occlusive disease.
Gherlinzoni F; Vianelli N; Valdrè L; Catani L; Tani M; Tura S
Haematologica; 1999 Feb; 84(2):191-2. PubMed ID: 10091426
[No Abstract] [Full Text] [Related]
18. Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator or orthotopic liver transplantation after allogeneic bone marrow transplantation.
Hágglund H; Ringdén O; Ericzon BG; Duraj F; Ljungman P; Lönnqvist B; Winiarski J; Tydén G
Transplantation; 1996 Oct; 62(8):1076-80. PubMed ID: 8900305
[TBL] [Abstract][Full Text] [Related]
19. Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation.
Park YD; Yasui M; Yoshimoto T; Chayama K; Shimono T; Okamura T; Inoue M; Yumura-Yagi K; Kawa-Ha K
Bone Marrow Transplant; 1997 May; 19(9):915-20. PubMed ID: 9156266
[TBL] [Abstract][Full Text] [Related]
20. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia.
Lee JH; Lee KH; Choi SJ; Min YJ; Kim JG; Kim S; Lee JS; Kim SH; Park CJ; Chi HS; Kim WK
Bone Marrow Transplant; 2000 Sep; 26(6):657-62. PubMed ID: 11041568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]